Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
3.720
+0.035 (0.95%)
At close: Aug 1, 2025, 4:00 PM
3.750
+0.030 (0.81%)
After-hours: Aug 1, 2025, 7:47 PM EDT
CTI BioPharma Market Cap
Akebia Therapeutics has a market cap or net worth of $977.01 million as of August 1, 2025. Its market cap has increased by 228.29% in one year.
Market Cap
977.01M
Enterprise Value
1.06B
1-Year Change
228.29%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has increased from $488.10M to $977.01M, an increase of 100.16%. That is a compound annual growth rate of 6.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 967.80M | 133.49% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 681.86B |
| Johnson & Johnson | 401.66B |
| AbbVie | 342.75B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 233.44B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.91B |
| Novo Nordisk | 221.96B |